Table 3. Differences in the effect of antihypertertensive drug therapy on systolic blood pressure in Users* and Non-users.† .
| Total | Beta blockers | Diuretics | ACE inhibitors | Calcium channel blockers |
|
| Change in systolic blood pressure‡ (mmHg) | |||||
| User*§ | -24.2 ± 18.9 | -27.3 ± 20.9 | -18.8 ± 17.9 | -22.4 ± 17.4 | -26.3 ± 19.3 |
| Non-user†§ | -26.2 ± 19.3 | -27.8 ± 19.6 | -24.4 ± 16.6 | -24.6 ± 19.5 | -29.6 ± 18.1 |
| Difference in the change in systolic blood pressure (mmHg) | |||||
| crude | 1.98 | 0.45 | 5.62 | 2.19 | 3.30 |
| (95% CI) | (-0.53, 4.48) | (-4.30, 5.20) | (-4.47, 15.71) | (1.24, 5.63) | (-3.52, 10.12) |
| adjusted|| | 2.88 | 0.37 | 6.11 | 3.85 | 3.50 |
| (95% CI) | (0.89, 4.87) | (-3.24, 3.98) | (-3.16, 15.37) | (1.16, 6.66) | (-2.03, 9.02) |
ACE: inhibitors: angiotensin-converting enzyme inhibitors
CI: confidence interval
* : Those co-administered antihypertensive and nonsteroidal anti-inflammatory drugs
† : Those not co-administered antihypertensive and nonsteroidal anti-inflammatory drugs
‡ : Change in the baseline systolic blood pressure after 2 months
§ : Mean ± standard deviation
|| : Adjusted for sex, age, classification of hypertension by extent of organ damage baseline systolic blood pressure, Drug Use Investigation, the use of medications that influence hypertension, and complications